BIANCO, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 175
NA - Nord America 99
AS - Asia 67
AF - Africa 11
SA - Sud America 2
Totale 354
Nazione #
US - Stati Uniti d'America 97
DE - Germania 94
IT - Italia 38
VN - Vietnam 18
TW - Taiwan 13
CN - Cina 11
GB - Regno Unito 11
FR - Francia 8
CI - Costa d'Avorio 7
JP - Giappone 7
IN - India 6
IE - Irlanda 5
RU - Federazione Russa 5
PH - Filippine 3
UA - Ucraina 3
BE - Belgio 2
CA - Canada 2
CH - Svizzera 2
DZ - Algeria 2
EC - Ecuador 2
IR - Iran 2
KR - Corea 2
MK - Macedonia 2
NL - Olanda 2
PK - Pakistan 2
BD - Bangladesh 1
FI - Finlandia 1
MA - Marocco 1
MY - Malesia 1
PT - Portogallo 1
SI - Slovenia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 354
Città #
Columbus 24
Dong Ket 14
Williamsburg 11
Nürnberg 10
Ann Arbor 9
Ashburn 7
Milan 5
Napoli 5
Buffalo 4
Shanghai 4
University Park 4
Beijing 3
Boardman 3
Caserta 3
Naples 3
Saint Petersburg 3
San Jose 3
Turin 3
Angeles City 2
Basking Ridge 2
Bolzaneto 2
Exeter 2
Ferrara 2
Formia 2
Hanoi 2
Heidelberg 2
Houston 2
Mountain View 2
New York 2
Sangolqui 2
Saïda 2
Taipei 2
Wuhan 2
Amsterdam 1
Bac Ninh 1
Bayan Lepas 1
Belfast 1
Bengaluru 1
Billingham 1
Boston 1
Brindisi 1
Cambridge 1
Eboli 1
Essen 1
Florence 1
Fremont 1
Gentbrugge 1
Ghent 1
Islamabad 1
Johannesburg 1
Kansas City 1
Kocaeli 1
Lahore 1
Lake Forest 1
Lappeenranta 1
Leeds 1
Milpitas 1
Montréal 1
Mysore 1
Nanjing 1
New Orleans 1
Nuremberg 1
Oakland 1
Ottawa 1
Paris 1
Pars 1
Pietra Ligure 1
Pune 1
Rabat 1
San Mateo 1
Sorbolo 1
Thanh Chuong 1
Trieste 1
Woodbridge 1
Totale 189
Nome #
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase III trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non-small cell lung cancer, file e268a72d-418d-4c8f-e053-1705fe0a812c 117
AXL is an oncotarget in human colorectal cancer, file e268a72c-fcf2-4c8f-e053-1705fe0a812c 65
Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents, file e268a72e-fcfa-4c8f-e053-1705fe0a812c 54
Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials, file e268a732-8f7e-4c8f-e053-1705fe0a812c 29
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients, file e268a733-67f7-4c8f-e053-1705fe0a812c 22
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs., file e268a72c-d2cc-4c8f-e053-1705fe0a812c 14
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers, file e268a732-d46e-4c8f-e053-1705fe0a812c 13
Association of FGFR1 with ERαmaintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer, file e268a732-d46c-4c8f-e053-1705fe0a812c 11
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer, file e268a732-de3e-4c8f-e053-1705fe0a812c 10
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments, file bd8e05fc-76aa-4ef3-b5ce-b6e4d6ee52b1 9
MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1, file e268a72c-fec6-4c8f-e053-1705fe0a812c 7
Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC, file 19ad087f-db1e-492d-a34f-635e266dd437 5
SPHINGOSINE KINASE 1 (SPHK1) CONTRIBUTES TO RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS IN COLORECTAL CANCER MODELS, file e268a72c-d2ac-4c8f-e053-1705fe0a812c 4
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer., file e268a72c-b893-4c8f-e053-1705fe0a812c 1
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES., file e268a72c-b894-4c8f-e053-1705fe0a812c 1
Totale 362
Categoria #
all - tutte 964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 3 9
2019/202033 2 3 2 4 0 1 1 13 0 3 3 1
2020/202122 1 2 1 1 2 1 1 0 3 2 1 7
2021/202225 7 0 0 0 1 1 0 3 5 3 5 0
2022/202330 0 3 1 3 1 2 0 2 4 1 12 1
2023/202479 2 0 4 4 2 8 6 9 3 7 34 0
Totale 362